Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan
Clinical trial NCT03595709 · COMPLETED
Trial details
- NCT number
- NCT03595709
- Sponsor
- Yu-Jay Corp.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2019-03-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.